€2m raised in seed funding to develop novel therapies for Cystic Fibrosis
Drug Discovery World
JUNE 19, 2023
This investment from the AFB FII fund stems from the AdBio-Inserm Transfert partnership announced in May 2022 to finance, support and grow Europe’s most innovative life science startups. Anoat will use the funds to conduct additional in vivo and in vitro pharmacology assessments and select a lead candidate.
Let's personalize your content